Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Non Operating Income: 2009-2024

Historic Non Operating Income for Assembly Biosciences (ASMB) over the last 14 years, with Dec 2024 value amounting to $5.6 million.

  • Assembly Biosciences' Non Operating Income rose 25.61% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 20.55%. This contributed to the annual value of $5.6 million for FY2024, which is 61.49% up from last year.
  • Assembly Biosciences' Non Operating Income amounted to $5.6 million in FY2024, which was up 61.49% from $3.5 million recorded in FY2023.
  • Over the past 5 years, Assembly Biosciences' Non Operating Income peaked at $5.6 million during FY2024, and registered a low of $302,000 during FY2021.
  • For the 3-year period, Assembly Biosciences' Non Operating Income averaged around $3.3 million, with its median value being $3.5 million (2023).
  • As far as peak fluctuations go, Assembly Biosciences' Non Operating Income plummeted by 88.49% in 2021, and later skyrocketed by 238.41% in 2022.
  • Yearly analysis of 5 years shows Assembly Biosciences' Non Operating Income stood at $2.6 million in 2020, then crashed by 88.49% to $302,000 in 2021, then soared by 238.41% to $1.0 million in 2022, then skyrocketed by 237.67% to $3.5 million in 2023, then skyrocketed by 61.49% to $5.6 million in 2024.